Abstract

22/03/2018
Speeding towards individualized treatment for pancreatic cancer by taking an alternative road

Speeding towards individualized treatment for pancreatic cancer by taking an alternative road

Speeding towards individualized treatment for pancreatic cancer by taking an alternative road. Iovanna J1, Dusetti N2. Abstract Accumulation of genetic mutations drives the development of pancreatic ductal […]
04/12/2017

Olivier DUCHAMP, IMODI coordinator, co-author of “PDX-MI Minimal Information for Patient-Derived Tumor Xenograft Models” publication

PDX-MI Minimal Information for Patient-Derived Tumor Xenograft Models With the participation of IMODI consortium Abstract Patient-derived tumor xenograft (PDX) mouse models have emerged as an important […]
15/10/2017
Oncodesign will be present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: October 26-30, Philadelphia, USA, Hall E

MEET IMODI EXPERTS at AACR-NCI-EORTC International Conference (USA, Philadelphia, October 26-30)

02/05/2017

Olivier DUCHAMP, IMODI coordinator, co-author of the book: Patient Derived Tumor Xenograft Models

Patient Derived Tumor Xenograft Models Promise, Potential and Practice Edited by Rajesh Uthamanthil, Peggy Tinkey Associate Editor : Elisa de Stanchina Patient Derived Tumor Xenograft Models: Promise, […]
24/04/2017

New results on the mechanism of drug resistance in AML (Acute Myeloid Leukemia) published in Cancer Discovery by the Team RESISTAML (INSERM U1037) headed by Dr. Jean-Emmanuel Sarry, IMODI Partner

Chemotherapy Resistant Human Acute Myeloid Leukemia Cells are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism Farge T1, Saland E1, de Toni F1, Aroua […]